HighTower Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$35.6M Sell
109,265
-4,592
-4% -$1.5M 0.04% 407
2025
Q1
$30.7M Sell
113,857
-1,523
-1% -$411K 0.04% 419
2024
Q4
$27.2M Sell
115,380
-410
-0.4% -$96.5K 0.04% 434
2024
Q3
$31.9M Sell
115,790
-9,251
-7% -$2.55M 0.05% 390
2024
Q2
$30.4M Sell
125,041
-1,039
-0.8% -$253K 0.05% 378
2024
Q1
$18.8M Buy
126,080
+1,860
+1% +$277K 0.03% 491
2023
Q4
$23.8M Sell
124,220
-219
-0.2% -$42K 0.04% 425
2023
Q3
$22.1M Sell
124,439
-1,347
-1% -$239K 0.04% 413
2023
Q2
$23.9M Buy
125,786
+226
+0.2% +$43K 0.05% 368
2023
Q1
$25.1M Sell
125,560
-182
-0.1% -$36.4K 0.05% 341
2022
Q4
$29.9M Sell
125,742
-1,122
-0.9% -$267K 0.07% 287
2022
Q3
$25.4M Sell
126,864
-4,438
-3% -$888K 0.07% 287
2022
Q2
$19.1M Sell
131,302
-3,387
-3% -$494K 0.05% 357
2022
Q1
$22M Buy
134,689
+5,036
+4% +$822K 0.05% 351
2021
Q4
$22M Buy
129,653
+123,016
+1,853% +$20.9M 0.05% 357
2021
Q3
$1.26M Buy
6,637
+42
+0.6% +$7.96K ﹤0.01% 1524
2021
Q2
$1.12M Sell
6,595
-78
-1% -$13.2K ﹤0.01% 1563
2021
Q1
$937K Buy
6,673
+799
+14% +$112K ﹤0.01% 1603
2020
Q4
$761K Sell
5,874
-113
-2% -$14.6K ﹤0.01% 1403
2020
Q3
$872K Sell
5,987
-166
-3% -$24.2K ﹤0.01% 1278
2020
Q2
$913K Sell
6,153
-2
-0% -$297 0.01% 1165
2020
Q1
$677K Sell
6,155
-4
-0.1% -$440 ﹤0.01% 1182
2019
Q4
$711K Buy
6,159
+255
+4% +$29.4K ﹤0.01% 1284
2019
Q3
$473K Buy
5,904
+205
+4% +$16.4K ﹤0.01% 1542
2019
Q2
$417K Sell
5,699
-645
-10% -$47.2K ﹤0.01% 1607
2019
Q1
$590K Hold
6,344
﹤0.01% 1375
2018
Q4
$463K Sell
6,344
-50
-0.8% -$3.65K ﹤0.01% 1389
2018
Q3
$564K Buy
+6,394
New +$564K ﹤0.01% 1405
2017
Q3
Sell
-3,900
Closed -$311K 2115
2017
Q2
$311K Sell
3,900
-717
-16% -$57.2K ﹤0.01% 1599
2017
Q1
$237K Buy
+4,617
New +$237K ﹤0.01% 1673
2016
Q4
Sell
-4,023
Closed -$271K 1881
2016
Q3
$271K Buy
4,023
+198
+5% +$13.3K ﹤0.01% 1499
2016
Q2
$211K Sell
3,825
-197
-5% -$10.9K ﹤0.01% 1465
2016
Q1
$250K Sell
4,022
-119
-3% -$7.4K ﹤0.01% 1629
2015
Q4
$388K Sell
4,141
-26
-0.6% -$2.44K ﹤0.01% 1441
2015
Q3
$334K Buy
+4,167
New +$334K ﹤0.01% 1401